After quite a crushing bull stampede in 2024, the stock price of weight loss drug star Novo Nordisk (NYSE: NVO) has come down ...

Lars Fruergaard Jørgensen might not be a household name, but his company’s drug Ozempic is. And its success has thrust him — ...

Novo Resources is pushing ahead on multiple exploration fronts across Australia ahead of drilling at its John Bull and ...

The popular medications may still suffer from local shortages, but FDA is confident that the national supply will remain ...

Drug compounders aren’t ready to give up their ability to produce off-brand versions of Novo Nordisk’s weight-loss drug ...

AstraZeneca has opened a plant to produce biogas from organic waste that will ensure by the end of this year all of its ...

HIGHLIGHTS Geological and geochemical sampling campaigns designed to guide effective targeting for drill programs in Q2 2025 ...

Medicare spending on some diabetes drugs, including popular treatments such as Ozempic, surged nearly five-fold to $35.8 ...

Ginkgo Bioworks' restructuring has resulted in a dramatic reduction in cash burn in recent quarters. Read why I think DNA ...

Novo Nordisk A/S, Apollo Global Management, BlackRock, Blackstone, Prologis, Welltower, and Ventas are the seven Growth ...

Eli Lilly ( LLY) announced Wednesday that it is ramping up US manufacturing, adding four new sites to help increase the ...

The FDA recently removed semaglutide from its drug shortage list, which has not been considered commercially available since ...